ruxolitinib

myeloproliferative leukemia virus oncogene ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29042365 Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. 2017 Dec 28 1
2 24251790 Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors. 2013 Nov 1